MedPath

BELIDE: Better Living With Non-memory-led Dementia

Not Applicable
Recruiting
Conditions
Dementia
Interventions
Behavioral: Better Living with Non-memory led Dementia programme
Other: Waiting list
Registration Number
NCT06241287
Lead Sponsor
University College, London
Brief Summary

Around 48 million people worldwide 1 live with dementia, of whom 3.9 million start with symptoms before the age of 65 (young-onset dementia). Most of the people presenting with young-onset dementia and some people with later onset dementia develop non-memory led dementias such as the atypical forms of Alzheimer ́s disease (AD)or frontotemporal dementia (FTD). Despite the proven benefits of educational programmes and skill training for caregivers, families of people with non-memory led dementias encounter fewer opportunities to receive this type of support. This is a significant gap in care considering that many people with young-onset non-memory led dementia are in their 50s or early 60s, which carries additional challenges about employment, financial stability, and childcare responsibilities. Finding suitable information and resources is less likely due to the lower prevalence of these phenotypes, their consequent geographical spread, and their atypical symptoms. Caregivers demands for more phenotype-specific support suggest that tailored provision of education and training is a gap in the provision of care in these types of dementia.

The aim of this study is to:

1. Determine the effectiveness of the Better Living with Non-memory Dementia educational programme for caregivers in improving psychological outcomes \[WS1\]; and

2. Conduct a mixed methods process analysis to elucidate mechanisms of change, barriers and facilitators to access and implementation as well as perceived benefits and costs \[WS2\].

The design is a randomised waiting list control trial with an 8-week intervention and 6-month follow-up comparing intervention to standard care with embedded process analysis. The intervention comprises a virtual onboarding session with a facilitator, 6 learning modules (including module-end real-life tasks to put skills into practice) and up to two further virtual check-in sessions with the facilitator. Intervention adaptation, adaptation to design and selection of primary outcome measures was based on feasibility work.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
238
Inclusion Criteria
  1. Adults (18+) who self-identify as an unpaid carer (partners, children, friends, etc.) of someone with PPA, PCA or bvFTD who is not living in a full-time care facility.
  2. The care recipient must have a confirmed diagnosis of dementia (through self- report of the carer, to reflect the 'real world' application of the intervention).
  3. Able to give informed consent.
  4. Good comprehension of written English.
  5. Access to the internet.
  6. Having a minimum amount of input in the care of the person with dementia (weekly contact).
Exclusion Criteria
  1. Carers of people living with dementia in full time care facility.
  2. Carers of a people with severe dementia in terms of large impact on activities of daily living. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Intervention groupBetter Living with Non-memory led Dementia programmeThe intervention group will receive the Better Living with Non-memory led Dementia programme, an 8-week duration 6-module educational programme covering the following topics: 1) Welcome to the programme and what to expect from it; 2) Understanding the disease; 3) How to provide better support for the person with dementia; 4) How to look after the caregiver's own mental health; 5) Where to find additional sources of support, and 6) An introduction to the value of support groups.
Control groupWaiting listThe waiting list control group will receive signposting to the publicly available Rare Dementia Support website (https://www.raredementiasupport.org/) and any kind of support the participants may already being receiving (e.g. psychological support, online information, support groups, etc). This a wait list study where the control group will be given access to the intervention ́s educational modules and material after the individuals' last point of data collection.
Primary Outcome Measures
NameTimeMethod
Patient Health Questionnaire (PHQ 9)8 week

Are Patient Health Questionnaire (PHQ 9) scores significantly decreased in caregiver participants allocated to receive the intervention compared to participants allocated to a waiting list control group.

Scores can range from 0 to 27. Higher score mean worse outcome.

Secondary Outcome Measures
NameTimeMethod
Quality of Carer-Patient relationship (QCPR)8 week

Measures the quality of the carer patient relationship.

Scores can range from 14 to 70. Higher score mean better outcome.

Perceived Stress Scale (PSS)8 week

Measures perceived stress.

Scores can range from 0 to 40. Higher score mean worse outcome.

Health related quality of life (EQ5D5L)8 week

EuroQol Group tool to measure quality of life related to health outcomes.

Scores can range from 5 to 25. Higher score mean better outcome.

Caregiver Self-efficacy Scale (CSES-8). Scores can range from 1 to 10. Higher score mean better outcome.8 week

Measures perceived caregiver self-efficacy

ICEpop Capability measure for adults (ICECAP-A)8 weeks

Measures capability for the general adult population for use un economic evaluation.

Scores can range from 5 to 25. Higher score mean better outcome.

Trial Locations

Locations (1)

University College London

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath